Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Badalamenti

Showing results (471-480 of 550) with videos related to

Pageof 55
Sort By:
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
ESMO Open|August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedgeM Bono, D Fanale, L Incorvaia, et al.
Endocrine|March 16, 2019
Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS groupAntongiulio Faggiano, Silvana Di Maio, Carmela Mocerino, et al.
Frontiers in Oncology|June 28, 2021
Prevalence and Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the GenomeDaniele Fanale, Alessia Fiorino, Lorena Incorvaia, et al.
Cancers|December 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective StudyValerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Therapeutic Advances in Medical Oncology|September 6, 2018
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenibBruno Vincenzi, Margherita Nannini, Giuseppe Badalamenti, et al.
Molecular Oncology|January 9, 2025
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective studyValerio Gristina, Viviana Bazan, Nadia Barraco, et al.
European Journal of Endocrinology|October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patientsDeborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Sensors (Basel, Switzerland)|May 19, 2019
Application of Hyperspectral Imaging to Underwater Habitat Mapping, Southern Adriatic SeaFederica Foglini, Valentina Grande, Fabio Marchese, et al.
NPJ Precision Oncology|September 5, 2024
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumorsLorena Incorvaia, Tancredi Didier Bazan Russo, Valerio Gristina, et al.
Pageof 55

Showing results (471-480 of 550) with videos related to

Sort By:
Pageof 55
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
ESMO Open|August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedgeM Bono, D Fanale, L Incorvaia, et al.
Endocrine|March 16, 2019
Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS groupAntongiulio Faggiano, Silvana Di Maio, Carmela Mocerino, et al.
Frontiers in Oncology|June 28, 2021
Prevalence and Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the GenomeDaniele Fanale, Alessia Fiorino, Lorena Incorvaia, et al.
Cancers|December 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective StudyValerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Therapeutic Advances in Medical Oncology|September 6, 2018
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenibBruno Vincenzi, Margherita Nannini, Giuseppe Badalamenti, et al.
Molecular Oncology|January 9, 2025
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective studyValerio Gristina, Viviana Bazan, Nadia Barraco, et al.
European Journal of Endocrinology|October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patientsDeborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Sensors (Basel, Switzerland)|May 19, 2019
Application of Hyperspectral Imaging to Underwater Habitat Mapping, Southern Adriatic SeaFederica Foglini, Valentina Grande, Fabio Marchese, et al.
NPJ Precision Oncology|September 5, 2024
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumorsLorena Incorvaia, Tancredi Didier Bazan Russo, Valerio Gristina, et al.
Pageof 55